A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma

NCT03377179 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholangiocarcinoma
Cholangiocarcinoma Non-resectable
Cholangiocarcinoma, Perihilar
Cholangiocarcinoma, Extrahepatic
Cholangiocarcinoma, Intrahepatic

Interventions

DRUG: ABC294640
DRUG: Hydroxychloroquine Sulfate 200 MG

Sponsor

RedHill Biopharma Limited